SEC Form 4 · accession 0000899243-15-010512
ANALOGIC CORP · ALOG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mervat Faltas
Officer — See Remarks
Period of report
Dec 29, 2015
Accepted (ET)
Dec 30, 2015 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000006284
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 29, 2015 | M | 2,181 | $45.98 | A | 11,843 | D | |
| Common StockF1 | Dec 29, 2015 | S | 2,181 | $85.162 | D | 9,662 | D | |
| Common Stock | Dec 29, 2015 | M | 3,686 | $70.04 | A | 13,348 | D | |
| Common StockF1 | Dec 29, 2015 | S | 3,686 | $85.162 | D | 9,662 | D | |
| Common Stock | Dec 29, 2015 | M | 3,486 | $77.08 | A | 13,148 | D | |
| Common StockF1 | Dec 29, 2015 | S | 3,486 | $85.162 | D | 9,662 | D | |
| Common Stock | Dec 29, 2015 | M | 1,871 | $71.09 | A | 11,533 | D | |
| Common StockF1 | Dec 29, 2015 | S | 1,871 | $85.162 | D | 9,662 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy)F2 | $45.98 | Dec 29, 2015 | M | 2,181 | D | — | Sep 15, 2018 | Common Stock | 2,181 | 0 | D |
| Non-Qualified Stock Option (Right to Buy)F3 | $70.04 | Dec 29, 2015 | M | 3,686 | D | — | Sep 10, 2019 | Common Stock | 3,686 | 0 | D |
| Non-Qualified Stock Option (Right to Buy)F4 | $77.08 | Dec 29, 2015 | M | 3,486 | D | — | Sep 10, 2020 | Common Stock | 3,486 | 1,742 | D |
| Non-Qualified Stock Option (Right to Buy)F5 | $71.09 | Dec 29, 2015 | M | 1,871 | D | — | Sep 9, 2021 | Common Stock | 1,871 | 3,741 | D |
Explanation of responses
- F1The shares were sold in multiple transactions on December 29, 2015 at an actual price ranging from $85.00 to $85.47 per share. The price reported reflects the weighted average sale price for the transactions. This reporting person undertakes to provide upon request by the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2The options became exercisable in three equal annual installments beginning 1 year from the grant date of 9/15/2011.
- F3The options became exercisable in three equal annual installments beginning 1 year from the grant date of 9/10/12.
- F4The options become exercisable in three equal annual installments beginning 1 year from the grant date of 9/09/2013.
- F5The options become exercisable in three equal annual installments beginning 1 year from the grant date of 09/09/2014.
Remarks
Sr VP & GM-Medical Imaging Business